The Asia Pacific TEO device market will see moderate growth through 2032 driven by the launch and increasing adoption of new devices backed by favorable clinical data, increasing access to the TEO…
The European PV device market will grow modestly over the forecast period, driven by increasing adoption of drug-eluting products as more clinical evidence for these technologies emerges, rising…
The European laparoscopic device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent…
The Asia Pacific gynecological device market will witness modest growth over the forecast period. This growth will primarily be driven by public and private efforts to increase awareness about…
The European biopsy device market was negatively impacted by the COVID-19 pandemic. However, overall biopsy procedure volumes will continue to grow marginally through 2032, driven by rise in cancer…
The US heart valve device market will continue to experience rapid growth, largely driven by the adoption of THV devices. Clinical investigations continue to generate positive results and propel…
The European CRM device market will continue to experience modest growth through 2032, primarily due to increasing adoption of premium-priced devices such as leadless pacemakers and S-ICDs. However…
The Asia Pacific small-joint reconstructive implant market remains relatively underdeveloped compared to the US and European markets, offering substantial growth potential. The adoption of small-…
The Japanese PV device market will continue to experience modest growth through 2032 primarily due to growth in the endovascular procedure volumes along with the rising adoption of premium-priced…
The European PV device will grow modestly through 2032. Market expansion will be driven by an increasing PAD patient pool, adoption of drug-eluting technologies, and a rising preference for the…
The European cardiac assist market will continue to experience modest growth through 2032 after recovering from the impact of COVID-19. Growth will primarily be driven by the temporary VAD devices…
The Japanese gynecological device market will witness slow growth over the forecast period, primarily driven by increased patient awareness, physician preference for noninvasive techniques, and the…
The US diabetes care device market has shown strong recovery from the short-term negative impacts of the COVID-19 pandemic and will resume prepandemic growth trends in the coming years. Market…
The Asia Pacific PV device market will grow modestly over the forecast period, driven by the high prevalence of PAD, an expanding patient population, and rising adoption of premium-priced drug-…
Following the impact of the COVID-19 pandemic, the European spinal implant market experienced strong growth in 2022 as deferred procedures were rescheduled. The market will continue to experience…